A Supramolecular Salicylic Acid-Betaine with Superior Epidermal Benefits and Better Tolerance: In vitro Proof of Concept Studies
Skin Pharmacology and Physiology · 29.01.2026 · 39 (2) · 47-57
DOI: 10.1159/000550692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Pharmacology and Physiology, online erschienen am 29.01.2026. Verfasst von Yanfeng Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Research, L'Oréal Research & Innovation China, Shanghai, China. Hauptthemen laut MEDLINE: Salicylic Acid, Betaine, Epidermis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
Recent progress in supramolecule research has led to a surge in its application in cosmetic products. However, comprehensive investigation of the potential benefits, especially differentiating biological activities and associating that with physical-chemical properties, remains to be established. The current study aimed to investigate the supramolecular salicylic acid-betaine (Supra-SA-B) compared to its physical mixture (SA+B) for effects on epidermal homeostasis and topical insult potential.
Methods
The structure of supra-SA-B and SA+B was characterized by a powder X-ray diffractometer. Skin tolerance was evaluated by applying SA, Supra-SA-B, and SA+B to human keratinocytes or SkinEthic™ reconstructed human epidermis (RHE) models. Inflammatory cytokines were assessed by Luminex assay. Histological morphology was evaluated by hematoxylin-eosin staining, with aquaporin-3 (AQP3) and Ki67 measured by immunofluorescence. RNA sequencing characterized overall biological response.
Results
Characteristic peaks remained the same for Supra-SA-B after freeze-drying verified that their crystalline structures were retained in the current solution. Supra-SA-B treated groups demonstrated significantly higher viabilities compared to SA or SA+B. With 18-h of treatment, Supra-SA-B treated group released fewer cytokines. In addition, Supra-SA-B demonstrated a better hydration effect with increased AQP3 expression and more organized epidermal structure. Consistent result was observed in the RNA transcriptomic profiles of RHE models. Supra-SA-B did not induce major transcriptome drift as compared to SA or SA+B, with less evident negative impact on loricrin, and late cornified envelope gene expression. Hyaluronic acid synthase boosting was maintained.
Conclusion
Supra-SA-B ameliorated skin tolerance risk for SA, enhanced hydration with less insult on barrier functions, suggesting promising potential for cosmetic application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Research, L'Oréal Research & Innovation China, Shanghai, China.
- Hangzhou International Innovation Institute, Beihang University, Hangzhou, China.
- Shenzhen Shinehigh Innovation Co., Ltd, Shenzhen, China.
- Advanced Research, L'Oréal Research & Innovation China, Shanghai, China, grace.gao@loreal.com.
Zitieren
APA
Liu, Y., Wang, W., Hu, Y., Zhang, M., Tao, Q., Huang, N., Wang, Z., Wang, H., Zhang, J., & Gao, Y. (2026). A Supramolecular Salicylic Acid-Betaine with Superior Epidermal Benefits and Better Tolerance: In vitro Proof of Concept Studies. Skin Pharmacology and Physiology, 39(2), 47-57. https://doi.org/10.1159/000550692
Vancouver
Liu Y, Wang W, Hu Y, Zhang M, Tao Q, Huang N, et al. A Supramolecular Salicylic Acid-Betaine with Superior Epidermal Benefits and Better Tolerance: In vitro Proof of Concept Studies. Skin Pharmacology and Physiology. 2026;39(2):47-57. doi:10.1159/000550692
BibTeX
@article{Liu2026,
author = {Liu, Yanfeng and Wang, Wei and Hu, Ya and Zhang, Mei and Tao, Qingsheng and Huang, Nan and Wang, Zhenyuan and Wang, Hao and Zhang, Jiaheng and Gao, Yu},
title = {A Supramolecular Salicylic Acid-Betaine with Superior Epidermal Benefits and Better Tolerance: In vitro Proof of Concept Studies},
journal = {Skin Pharmacology and Physiology},
year = {2026},
volume = {39},
number = {2},
pages = {47--57},
doi = {10.1159/000550692}
}
EUVIMED